DRUG DEVELOPMENT DECONSTRUCTOR MANIFESTO: : “Tell me how you read and I'll tell you who you are.” ― Martin Heidegger
Sunday, October 6, 2013
Saturday, October 5, 2013
Friday, October 4, 2013
Top Biotechs Set to Win in the War on Cancer - cancer is scared to death!
Tuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech analysts at UBS. While the UBS team came away from ESMO with a much clearer picture of the competitive positioning and clinical profiles for many of the drugs from companies under their coverage, on balance this year’s ESMO meeting was much less stock-moving event than in years past.
One thing from the conference was extremely evident. The biotech sector remains catalyst-rich for the remainder of 2013, with key data readouts at several upcoming conferences to impact shares. In a new research report, UBS highlights the top names in the biotechnology world making huge strides to bring an end to a disease that killed almost 600,000 people in the United States alone in 2012.
Fecal Transplant, Now in Pill Form. Shit of the day.
Do not try it at home? Gel caps containing concentrated fecal microbes stopped recurrent Clostridium difficile infection and were well-tolerated by recipients, researchers reported here.
Erection as a critical resource
Call it the anti-Viagra. It's not a product for the man who can't get the party started. It's for the man who ends the party too soon.Competition is heating up to treat premature ejaculation, or PE, which may afflict one-in-three men at some point in their lives—and not just when they're teenagers.
Promescent, an FDA-approved, over-the-counter spray to treat PE. The spray uses lidocaine to reduce sensitivity and allow for longer performance. It is absorbed quickly so as not to be transferred to sexual partners. From here: http://www.nbcnews.com/business/new-sex-drug-men-too-much-hurry-8C11329732
Thursday, October 3, 2013
The many - the better?
Three parents and a disease-free baby
The upside of having three genetic parents
The U.K. government will allow scientists to create babies using DNA from three different parents—a positive development, according to some researchers, for parents with mitochondrial diseases.
The controversial procedure—also called mitochondrial replacement—is possible through in vitro fertilization (IVF). Mitochondrial diseases like muscular dystrophy affect about one in 5,000 people worldwide, so only a very small group of people would be interested in such a procedure, Virginia Hughes writes in Popular Science. The procedure would "be performed at a few select clinics in the U.K. and will be carefully monitored...[a]nd if not safe, it will most likely be banned."
Wednesday, October 2, 2013
Tuesday, October 1, 2013
Subscribe to:
Posts (Atom)